The North America Mental Health Screening Market would witness market growth of 11.8% CAGR during the forecast period (2024-2031).
The US market dominated the North America Mental Health Screening Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $635.7 million by 2031. The Canada market is experiencing a CAGR of 14.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.3% during (2024 - 2031).
Technological advancements have revolutionized the field of mental health screening, making it more accessible and convenient than ever before. Digital mental health screening tools, including mobile apps and online platforms, have emerged as effective and user-friendly solutions for assessing mental health status.
Moreover, these tools allow individuals to complete screening assessments at their convenience, from the comfort of their homes or on-the-go, without needing an in-person appointment.
The demand for mental health screening tools in North America is on the rise, fueled by alarming statistics that underscore the prevalence and impact of mental health disorders in the region. According to Statistics Canada data from 2022, over 5 million Canadians aged 15 and older, representing 18% of the population, met the diagnostic criteria for a mood, anxiety, or substance use disorder in the previous 12 months.
Free Valuable Insights: The Mental Health Screening Market is Predict to reach USD 2.4 Billion by 2031, at a CAGR of 12.5%
Based on Age Group, the market is segmented into Adults (age 19-64 years), Children & Adolescents (age 0-18 years), and Seniors (age 65 and above). Based on Setting, the market is segmented into Clinical Settings, Educational Institutions & Others, and Workplace/Corporate Programs & Online Platforms. Based on Technology, the market is segmented into Telehealth & Virtual Care Solutions, Self-screening mHealth Apps, AI-based Screening Tools, and Continuous Monitoring Wearable Devices & Others. Based on Screening Method, the market is segmented into Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, and Biomarker Testing. Based on Application, the market is segmented into Physiological Disorders (Depression & Anxiety, Eating Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, and Others), Psychiatric Disorders (Attention Deficit Hyperactivity Disorder (ADHD), Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Schizophrenia, and Others), Cognitive Disorders (Cognitive Impairment, Dementia, and Alzheimer's Disease & Others), and Behavioral Disorders (Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, and Others).Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Age Group
By Setting
By Technology
By Screening Method
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 